The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Mainz Biomed B.V.(NASDAQ:MYNZ) 
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoS...
Share this website to your friends
Mainz Biomed B.V. Days Payable Outstanding ttm (DPO)
Mainz Biomed B.V. Days Receivable Outstanding ttm (DSO)
Mainz Biomed B.V. Days Inventory Outstanding ttm (DIO)
Mainz Biomed B.V. Op Cashflow Per Share ttm
Mainz Biomed B.V. Free Cashflow Per Share ttm
Mainz Biomed B.V. Cash Per Share ttm
Mainz Biomed B.V. P/S ratio ttm
Mainz Biomed B.V. (GAAP) P/E ratio ttm
Mainz Biomed B.V. P/B ratio ttm
No extra charts and metrics for this ticker.